← SynDRA
HP-228
SynDRA canonical compound SYN1957158 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NOS2 |
|---|
| Mechanism of action | nitric oxide synthase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- nitric oxide synthase inhibitor
- NOS2 MODULATOR
Cross-references
Synonyms
- HP 228
- Ac-Nle-gln-his-D-phe-arg-D-trp-gly-NH2
- AC1L2XO7
- Acetyl-norleucyl-glutaminyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycinamide
- L-Norleucyl-L-glutaminyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycinamide
- Glycinamide, L-norleucyl-L-glutaminyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophyl-
- 3VG23J6Twx
- ILP-228
- UNII-3VG23J6TWX
- N-Acetyl-nle-Gln-His-D-Phe-Arg-D-Trp-Gly-NH2
- SCHEMBL306027
- SCHEMBL14188828
- SCHEMBL29357687
- hp228
- N-Acetyl-nle-Gln-His-D-Phe-Arg-D-Trp-Gly-NH2 dihydrochloride
- RefChem:201179
- UNII-CWS25FJB7N
- HP228 dihydrochloride
- HP-228 dihydrochloride
- CWS25FJB7N
Look up HP-228 in the interactive SynDRA portal →